Vaughn Hartung is the Co-Founder and Chief Technology Officer of FloraWorks. With a background in biochemistry, he leads the development and validation of cannabinoid therapeutics, including the flagship product, TruCBN. Vaughn's work has been instrumental in demonstrating the efficacy of TruCBN in improving sleep quality through clinical trials.